Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Rheumatology (Oxford, England)|January 13, 2023
A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS)Deborah J Griffiths-Jones, Yvonne Sylvestre Garcia, W David Ryder, et al.
Annals of the Rheumatic Diseases|June 14, 2013
Health-related utility values of patients with primary Sjögren's syndrome and its predictorsDennis Lendrem, Sheryl Mitchell, Peter McMeekin, et al.
Annals of the Rheumatic Diseases|May 8, 2012
Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren's syndromeJulia L Newton, James Frith, Danielle Powell, et al.
Swiss Medical Weekly|February 15, 2018
Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome RegistryAlexandre Dumusc, Wan-Fai Ng, Katherine James, et al.
Rheumatology (Oxford, England)|September 22, 2014
Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome?Dennis Lendrem, Sheryl Mitchell, Peter McMeekin, et al.
Rheumatology International|December 26, 2016
Physical activity but not sedentary activity is reduced in primary Sjögren's syndromeWan-Fai Ng, Ariana Miller, Simon J Bowman, et al.
Rheumatology Advances in Practice|March 16, 2023
Management of systemic sclerosis: British Society for Rheumatology guideline scopeChristopher P Denton, Enrico De Lorenzis, Elen Roblin, et al.
Rheumatology (Oxford, England)|September 10, 2024
The 2024 British Society for Rheumatology guideline for management of systemic sclerosis-executive summaryChristopher P Denton, Enrico De Lorenzis, Elen Roblin, et al.
Rheumatology (Oxford, England)|August 26, 2025
Coming to a hard stop? Effect of tapered tocilizumab after weekly tocilizumab cessation for giant cell arteritis: a multicentre evaluationVanessa Quick, Stephen Sah, Shirish Dubey, et al.
Rheumatology (Oxford, England)|September 10, 2024
The 2024 British Society for Rheumatology guideline for management of systemic sclerosisChristopher P Denton, Enrico De Lorenzis, Elen Roblin, et al.
Pageof 7